Contents
A hospice SSVI score combines Medicare spending outside the hospice benefit with patterns in the care a hospice bills, identifying providers whose claims differ from their peers. The Service and Spending Variation Index puts long stays, live discharges, visit intensity and outside spending into one number. If you work in a hospice, you may know the decisions behind that number: who approved an admission, why a discharge stalled, or what happened when a nurse questioned the chart.
The Centers for Medicare & Medicaid Services introduced the index in its fiscal 2027 hospice rule. For someone concerned about hospice fraud, the useful connection is between a claims pattern and the people, records and payments behind it.
A hospice SSVI score runs from zero to 16, combining a non-hospice spending score with a utilization score. The index uses nine claims-based measures, but gives them different weight: the single spending measure can contribute as many points as all the utilization measures together.
Under CMS’s scoring methodology, a hospice with no reported non-hospice spending receives zero spending points. The agency sorts the remaining hospices by total non-hospice spending into eight roughly equal groups. The spending score rises from one through eight as the spending group rises.
The utilization component starts at zero and adds one point for each flagged measure. Its maximum is eight. The component results show which measures contributed to the total, so the same overall score can come from different combinations of spending and service patterns.
The component, the year and the hospice billing identity give the number its meaning. In the overview’s fiscal 2025 distribution, 55 hospices scored 13, representing 0.8% of hospices. That is a rare result, and the component scores show which patterns drove it.
Hospice SSVI thresholds turn provider metrics into score components. For fiscal 2025, the Centers for Medicare & Medicaid Services overview gives these cutoffs. Its results for the latter half of that year may be incomplete.
| Utilization Measure | When the Measure Adds a Point in Fiscal 2025 |
|---|---|
| Continuous home care and general inpatient care | The hospice provides neither during the year. |
| Routine home care in a nursing facility or skilled nursing facility | At least 40% of all hospice days are routine home care in those settings. |
| Skilled visits near death | At most 87.5% of qualifying patients receive a skilled visit in their last two routine-home-care days of life. |
| Long stays | At least 33.3% of qualifying discharged beneficiaries have lifetime stays of 180 days or more. |
| Live discharge | At least 46.7% of qualifying discharges are alive. |
| Skilled nursing minutes | Average skilled nursing time is at most 9.9 minutes per routine-home-care day. |
| Weekend skilled visits | At most 4.8% of weekend routine-home-care days include a skilled visit. |
| Rapid return | At least 18.2% of live discharges are followed by a return to the same hospice within seven days. |
The visit and nursing-minute cutoffs mark the 25th percentile. The long-stay, live-discharge and rapid-return cutoffs mark the 75th percentile. These comparisons depend on the measured year’s provider distribution.
The measures count different parts of a patient’s care: days enrolled, discharge events and visits delivered. That is why a public percentage can look unlike the census or visit report used inside the business.
The long-stay measure uses a beneficiary’s final claim in the fiscal year and excludes patients still receiving hospice care and patients whose final claim shows a transfer. It then measures lifetime hospice days, including days before that fiscal year and care across multiple hospices.
A patient admitted recently to the current provider may already have a substantial hospice history. The score follows that history, beyond the current provider’s census.
For admission and recertification decisions, the clinical record supplies the other half of the story. Medicare’s eligibility standard is a prognosis of six months or less if the illness follows its normal course, and benefits can continue with supported recertification. We connect the recorded condition and the certification decision to the days Medicare paid for.
The overall live-discharge measure counts all qualifying discharges during the year, including repeated discharge events. Its denominator includes both live discharges and deaths. Transfers to another hospice stay out of that measure because the beneficiary remains in a hospice election.
The rapid-return measure asks a narrower question: did the beneficiary leave and return to the same hospice? This calculation includes transfer-coded departures among live discharges. A transfer can therefore enter the return calculation while being excluded from the overall live-discharge rate.
That distinction matters when a nurse remembers a patient moving between providers while the billing office sees a discharge code. The episode and the coding need to be understood together.
The near-death measure selects beneficiaries who died in hospice and whose last two hospice days were consecutive and billed as routine home care. It asks whether they received at least one skilled visit during those days.
For that measure, skilled visits include nursing, medical social services and therapy. The nursing-minutes measure, by contrast, counts skilled nursing minutes per routine-home-care day. Weekend coverage uses weekend routine-home-care days as its denominator. Each gives a different view of the work billed around the patient.
Non-hospice spending is Medicare payment outside the hospice benefit while a beneficiary has elected hospice. The index draws on non-hospice Part A and Part B claims and Part D prescription drug events, alongside hospice claims.
The index scores the total outside spending associated with the hospice’s beneficiaries. The highest spending band in fiscal 2025 began above roughly $517,204. A hospice in that band receives all eight spending points.
The payment arrangement explains the scrutiny. A hospice takes responsibility for care related to the terminal illness, while Medicare can continue paying separately for unrelated care and certain independent attending-physician services. In a hospice billing inquiry, the connection is between the outside service, its relationship to the patient’s illness and the claim that paid for it.
The agency’s fiscal 2027 final rule reported more than $2.8 billion in non-hospice spending across Parts A, B and D during hospice elections in fiscal 2024. Beneficiaries also faced cost sharing for outside care. Medicare pays the hospice, yet the patient can still face another health care bill.
For hospice elections beginning on or after October 1, 2026, the rule requires the hospice to give the patient or representative an election statement addendum listing conditions, items, services and drugs it considers unrelated and will not cover. That form records the hospice’s decision about which care falls outside its responsibility. Admissions staff who know why an item went on that list can explain a decision the spending total leaves out.
Medicare’s daily payment gives a hospice revenue for each enrolled day, while the cost of providing care depends on the work. A long stay with few visits is financially attractive. That is why duration and service intensity belong in the same conversation.
The HHS Office of Inspector General examined this incentive in Medicare Hospices Have Financial Incentives To Provide Care in Assisted Living Facilities, published in 2015. Its analysis used Medicare hospice claims from 2007 through 2012 and found longer care and higher payments for beneficiaries in assisted living than in other settings:
Hospices typically provided fewer than 5 hours of visits and were paid about $1,100 per week for each beneficiary receiving routine home care in ALFs.
The report recommended targeted review, claims-based quality measures, public hospice data and information showing providers how they compared with peers. The Centers for Medicare & Medicaid Services agreed with those recommendations. The payment incentive and the demand for better comparisons predate the Service and Spending Variation Index.
A 2026 Kansas State University working paper, Quality, Reputation, and Reimbursement Design in the Hospice Industry, approaches the incentive through an economic model of California hospices. It uses visits per patient-day as its measure of quality and effort. The model finds that reputation can encourage more care, while lower daily reimbursement can reduce it. Those findings put business incentives beside the visit count.
The Service and Spending Variation Index compares spending and utilization variation. The Hospice Care Index is a separate quality measure built from ten claims-based indicators covering visits, live discharge, Medicare spending per beneficiary and high-intensity care.
Hospice early and late live discharge measures sit within HCI, alongside indicators involving hospitalization after discharge. SSVI’s overall live-discharge and same-hospice return measures use the populations described above.
Our whistleblower experts connect the patient’s condition, the service or discharge decision, the Medicare claim and who knew what. The strongest contribution an insider can make is explaining the decision that a percentage leaves out.
In the government’s complaint against Evercare, internal audits allegedly found charts that did not support terminal illness or certification. The complaint also described delayed nursing documentation and management control over admission decisions. One passage put the reason for keeping a patient particularly plainly:
But, according to the medical record, Evercare management directed “we are not to revoke this patient because ‘our census is too low.’”
The alleged instruction supplied a business reason for the decision recorded in the patient’s file. Evercare later agreed to an $18 million settlement over allegedly unsupported hospice eligibility. The useful parallel for an insider is the connection between a clinical concern, management’s response and continued billing.
A whistleblower’s amended complaint against Heartland alleged a similar influence over departures:
The Heartland process for allowing such “live discharges” was intentionally designed and enforced by Heartland executives to be slow, bureaucratic, multi-layered, and resistant to the medical judgments of Heartland’s own Medical Directors.
That complaint also alleged that management restricted reviews of earlier months after allowing a discharge. The question reached back to the payments already received, as well as the decision to end care.
For hospice fraud whistleblowers, original observations, later chart entries, internal audit findings and management instructions can explain how the billed care took shape. Our whistleblower experts use that inside knowledge to build a healthcare fraud case with you. A whistleblower case under the False Claims Act can pay 15% to 30% of what the government recovers.
If you know who kept patients enrolled, changed the chart or disregarded a clinical warning, speak with our whistleblower experts about the decisions behind the hospice claims. We build the case with you and bring in hospice fraud whistleblower lawyers who understand eligibility, documentation and Medicare billing. We stay beside you as your partners through the case.